A combined observational and Mendelian randomization investigation reveals NMR-measured analytes to be risk … – Nature.com

Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 37(42), 32323245 (2016).

Article PubMed Google Scholar

Townsend, N. et al. Epidemiology of cardiovascular disease in Europe. Nat. Rev. Cardiol. 19(2), 133143 (2022).

Article PubMed Google Scholar

Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 19802017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392(10159), 17361788 (2018).

Article Google Scholar

Severino, P. et al. Ischemic heart disease and heart failure: Role of coronary ion channels. Int. J. Mol. Sci. 21(9), 3167 (2020).

Article CAS PubMed PubMed Central Google Scholar

Groenewegen, A., Rutten, F. H., Mosterd, A. & Hoes, A. W. Epidemiology of heart failure. Eur. J. Heart Fail. 22(8), 13421356 (2020).

Article PubMed Google Scholar

Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D. & Catapano, A. L. Global epidemiology of dyslipidaemias. Nat. Rev. Cardiol. 18(10), 689700 (2021).

Article CAS PubMed Google Scholar

Feingold, K. R. Introduction to lipids and lipoproteins (2015).

Moini, J. Epidemiology of Diet and Diabetes Mellitus. Epidemiology of Diabetes 2019. pp. 5773.

Lusis, A. J. & Pajukanta, P. A treasure trove for lipoprotein biology. Nature Genet. 40(2), 129130 (2008).

Article CAS PubMed Google Scholar

Asztalos, B. F. & Schaefer, E. J. High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol. 91(7A), 12E-E17 (2003).

Article CAS PubMed Google Scholar

Griffin, B. A. & Packard, C. J. Metabolism of VLDL and LDL subclasses. Curr. Opin. Lipidol. 5(3), 200206 (1994).

Article CAS PubMed Google Scholar

Ng, D. S., Wong, N. C. W. & Hegele, R. A. HDLis it too big to fail?. Nat. Rev. Endocrinol. 9(5), 308312 (2013).

Article CAS PubMed Google Scholar

Asztalos, B. F., Tani, M. & Schaefer, E. J. Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol. 22(3), 176185 (2011).

Article CAS PubMed Google Scholar

Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N. & Davey, S. G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27(8), 11331163 (2008).

Article MathSciNet PubMed Google Scholar

Zheng, J. et al. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 4(4), 330345 (2017).

Article PubMed PubMed Central Google Scholar

Haase, C. L. et al. LCAT, HDL cholesterol and ischemic cardiovascular disease: A Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocr Metab. 97(2), E248E256 (2012).

Article CAS PubMed Google Scholar

Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., et al. Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36(9):539 (2015).

Richardson, T. G. et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLOS Med. 17(3), e1003062 (2020).

Article PubMed PubMed Central Google Scholar

Lind, L., Ingelsson, M., Sundstrom, J., Arnlov, J. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings. Open Heart. 8(2) (2021).

Shah, S., Henry, A., Roselli, C., Lin, H., Sveinbjrnsson, G., Fatemifar, G., et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun. 11(1) (2020).

Srisawasdi, P. et al. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations. Clin Biochem. 46(15), 15091515 (2013).

Article CAS PubMed Google Scholar

Guo, Y. et al. Circulating metabolites associated with incident myocardial infarction and stroke: A prospective cohort study of 90 438 participants. J Neurochem. 162(4), 371384 (2022).

Article CAS PubMed Google Scholar

Lind, L. et al. Life-time covariation of major cardiovascular diseases: A 40-year longitudinal study and genetic studies. Circ Genom Precis Med. 14(2), e002963 (2021).

Article CAS PubMed PubMed Central Google Scholar

Lind, L., Fall, T., Arnlov, J., Elmstahl, S. & Sundstrom, J. Large-scale metabolomics and the incidence of cardiovascular disease. J Am Heart Assoc. 12(2), e026885 (2023).

Article CAS PubMed PubMed Central Google Scholar

Julkunen, H. et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 14(1), 604 (2023).

Article ADS CAS PubMed PubMed Central Google Scholar

Ingelsson, E., Arnlov, J., Sundstrom, J. & Lind, L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 7(5), 787791 (2005).

Article PubMed Google Scholar

Elsworth, B., Lyon, M., Alexander, T., Liu, Y., Matthews, P., Hallett, J., et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020:2020.08.10.244293.

An integrated map of genetic variation from 1092 human genomes. Nature. 491(7422):5665 (2012).

A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nature Genet. 47(10):11211130 (2015).

Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 611(7934), 115123 (2022).

Article CAS PubMed PubMed Central Google Scholar

Lind, L., Strand, R., Michaelsson, K., Ahlstrom, H. & Kullberg, J. Voxel-wise study of cohort associations in whole-body MRI: Application in metabolic syndrome and its components. Radiology. 294(3), 559567 (2020).

Article PubMed Google Scholar

Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 7 (2018).

Wurtz, P. et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 131(9), 774785 (2015).

Article PubMed PubMed Central Google Scholar

Holmes, M. V. et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 71(6), 620632 (2018).

Article CAS PubMed PubMed Central Google Scholar

Gu, X. et al. Association of lipids with ischemic and hemorrhagic stroke. Stroke. 50(12), 33763384 (2019).

Article PubMed Google Scholar

Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., et al. Apolipoprotein B and cardiovascular disease: Biomarker and potential therapeutic target. Metabolites 11(10) (2021).

Fu, C., Liu, D. B., Liu, Q., Wang, X. D., Ma, X. X., Pan, H., et al. Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors-a mendelian randomization analysis. Cardiovasc Diabetol. 23(1) (2024).

Calabresi, L., Simonelli, S., Gomaraschi, M. & Franceschini, G. Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis. 222(2), 299306 (2012).

Article CAS PubMed Google Scholar

Iatan, I., Palmyre, A., Alrasheed, S., Ruel, I. & Genest, J. Genetics of cholesterol efflux. Curr. Atherosclerosis Rep. 14(3), 235246 (2012).

Article CAS Google Scholar

Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362(17):15631574 (2010).

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365(24), 22552267 (2011).

Frikke-Schmidt, R. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA. 299(21), 2524 (2008).

Article CAS PubMed Google Scholar

White, J. et al. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol. 1(6), 692 (2016).

Article PubMed PubMed Central Google Scholar

Gerl, M. J., Klose, C., Surma, M. A., Fernandez, C., Melander, O., Mannisto, S., et al. Machine learning of human plasma lipidomes for obesity estimation in a large population cohort. Plos Biol. 17(10) (2019).

Zheng, R., Michalsson, K., Fall, T., Elmsthl, S., Lind, L. The metabolomic profiling of total fat and fat distribution in a multi-cohort study of women and men. Sci. Rep. 13(1) (2023).

Allara, E., Morani, G., Carter, P., Gkatzionis, A., Zuber, V., Foley, C. N., et al. Genetic determinants of lipids and cardiovascular disease outcomes. Circ.: Genom. Precis. Med. 12(12) (2019).

Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample Mendelian randomization. Genet. Epidemiol. 40(7), 597608 (2016).

Article PubMed PubMed Central Google Scholar

Read the original:
A combined observational and Mendelian randomization investigation reveals NMR-measured analytes to be risk ... - Nature.com